Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): A double-blind, randomised, placebo-controlled trial
- Submitting institution
-
University College London
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 5556
- Type
- D - Journal article
- DOI
-
10.1016/S2213-8587(17)30194-8
- Title of journal
- The Lancet Diabetes and Endocrinology
- Article number
- -
- First page
- 597
- Volume
- 5
- Issue
- 8
- ISSN
- 2213-8587
- Open access status
- Compliant
- Month of publication
- June
- Year of publication
- 2017
- URL
-
-
- Supplementary information
-
https://www.thelancet.com/cms/10.1016/S2213-8587(17)30194-8/attachment/efebdd35-ce62-4365-8004-976c1c8227cf/mmc1.pdf
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
15
- Research group(s)
-
-
- Citation count
- 129
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to: A (i) the conception and design of the study; A (ii) the organisation of the conduct of the study; A (iv) analysis and interpretation of study data; B (i) The author helped draft the output; B (ii) critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -